Sparro et al., 1997 - Google Patents
Isolation and N-terminal sequence of multiple forms of granulins in human urineSparro et al., 1997
View PDF- Document ID
- 8041323548489009258
- Author
- Sparro G
- Galdenzi G
- Eleuteri A
- Angeletti M
- Schroeder W
- Fioretti E
- Publication year
- Publication venue
- Protein expression and purification
External Links
Snippet
Three molecular forms of granulins (also known as epithelins) were isolated, for the first time, in human urine. Their N-terminal sequences, which have also been determined, are identical to those of granulins A and B, previously isolated from human leukocytes, and of …
- 102000017941 granulin family 0 title abstract description 40
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1241641A (en) | Osteogenic factors | |
Olsson et al. | Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells | |
Zeng et al. | Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart | |
Sparro et al. | Isolation and N-terminal sequence of multiple forms of granulins in human urine | |
CA2098921C (en) | Angiogenic peptides | |
JPH0764875B2 (en) | Novel polypeptide having anticoagulant effect | |
Odani et al. | Purification and complete amino acid sequence of novel β2-microglobulin | |
Rice et al. | Isolation and sequence of the vitamin K‐dependent matrix Gla protein from the calcified cartilage of the soupfin shark | |
Hale et al. | Carboxyl-terminal proteolytic processing of matrix Gla protein. | |
US4746729A (en) | Cartilage-derived leukocyte elastase-inhibitor | |
Kim et al. | Purification and characterization of a low molecular weight transforming growth factor from the urine of melanoma patients. | |
Burgos | Angiogenic factor from human term placenta. Purification and partial characterization | |
Gebauer et al. | Hemocyanin subunit organization of the gastropod Rapana thomasiana | |
Geiger et al. | The inhibition of human gingival collagenase by an inhibitor extracted from human teeth | |
CA2128215C (en) | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy | |
CN107406840A (en) | Method for purifying and quantifying thrombin and polypeptides degraded thereby | |
HK Weise et al. | Snake Venom Toxins. The Purification of Toxins V II 1 and V II 2, Two Cytotoxin Homologues from Banded Egyptian Cobra (Naja haje annulifera) Venom, and the Complete Amino Acid Sequence of Toxin V II 1 | |
LI et al. | Recombinant fish neurotrophin-6 is a heparin-binding glycoprotein: implications for a role in axonal guidance | |
JP3103531B2 (en) | Human urine-derived cell adhesion glycoprotein and method for producing the same | |
CA2292889C (en) | Process for the separation of glycosylated and nonglycosylated proteins | |
KR19980703851A (en) | Method for Purifying Glycoproteins such as Erythropoietin | |
Eddeland et al. | Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-α-macroglobulin | |
Ogata | Demonstration of pancreatic secretory trypsin inhibitor in serum-free culture medium conditioned by the human pancreatic carcinoma cell line CAPAN-1. | |
EP0239644A1 (en) | Novel physiologically active substance having blood coagulation controlling activity | |
Welinder et al. | Alternative mobile phases for the reversed-phase high-performance liquid chromatography of peptides and proteins |